When we first saw the news of the new antibiotic, we thought that it would be a simple fix for the bacteria, but it turns out that the new drug is actually more potent than the old one.
The drug is still used to treat bacteria like E. coli and MRSA, but this new version is able to kill them even more rapidly.
As the new drugs’ effectiveness is measured, it can help scientists make more precise decisions about which antibiotics are most effective for particular infections.
In fact, we’ll be testing the new medications in more than 20 clinical trials, including trials of patients with antibiotic-resistant bacterial infections like pneumonia and influenza.
This story has been updated to clarify that we tested beta lactamicin for MRSA and E.coli, not both.